Momentum Sunshine

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Type 2 diabetes4 trials
• Atopic dermatitis (eczema)1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Not yet recruiting3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Myopharm Limited1 trial
• Prana Therapies Inc1 trial

Running trials

• Not yet recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· Phase 3· Eli Lilly and Company· Source

  Contact: King Cheung (principal investigator)

• Recruiting

  PRA-216 Atopic Dermatitis Safety and Efficacy Study

  NCT07810777· Phase 2· Prana Therapies Inc· Source

  Contact: King Cheung, MD

• Not yet recruiting

  TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy

  NCT07139405· Phase 2· Myopharm Limited· Source

  Contact: Charles Czank, PhD MBA

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  NCT07321886· Phase 3· Eli Lilly and Company· Source

  Contact: King Cheung (principal investigator)

• Active, not recruiting

  A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  NCT07215559· Phase 2· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Type 2 diabetes3 recruiting
• Atopic dermatitis (eczema)1 recruiting